Restarting the trial will require the company to raise additional funds before its money runs out this summer.
The drug combines an RNAi payload with an agent designed to stimulate a patient's immune system against their tumors.
Available in March, the PCR-based FilmArray 2.0 platform has higher throughput and takes up a smaller footprint.
After reporting a sharp rise in revenues this week, Foundation Medicine discussed changes ahead for the company.
Meridian received the CE mark for two new Illumigene molecular diagnostic tests for Chlamydia trachomatis and Neisseria gonorrhoeae.
In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.
Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.
The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.
The House of Lords in the UK approves a bill to allow mitochondrial donation.